Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 10,184 | 19,518 | 6,870 | 7,849 | 20,640 |
| Gross Profit | 10,184 | 19,518 | 6,870 | 7,849 | 20,640 |
| Operating Expenses | 15,200 | 13,727 | 11,758 | 13,781 | 12,395 |
| Operating Income | -5,016 | 5,791 | -4,888 | -5,932 | 8,245 |
| Other Income | 351 | 324 | 524 | 363 | 123 |
| Pre-tax Income | -4,665 | 6,115 | -4,364 | -5,569 | 8,368 |
| Income Tax | 1 | N/A | -388 | 5 | -1,095 |
| Net Income Continuous | -4,666 | 6,115 | -3,976 | -5,574 | 9,463 |
| Net Income | $-4,666 | $6,115 | $-3,976 | $-5,574 | $9,463 |
| EPS Basic Total Ops | -0.12 | 0.16 | -0.10 | -0.15 | 0.25 |
| EPS Basic Continuous Ops | -0.12 | 0.16 | -0.10 | -0.15 | 0.26 |
| EPS Diluted Total Ops | -0.12 | 0.16 | -0.10 | -0.15 | 0.25 |
| EPS Diluted Continuous Ops | -0.12 | 0.16 | -0.10 | -0.15 | 0.26 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 0.16 | -0.10 | -0.15 | 0.25 |
| EBITDA(a) | $-4,613 | $6,226 | $-4,458 | $-5,509 | $8,669 |